Activation of the TGF-β/SMAD axis has long been recognized to facilitate the metastatic capacity of cancer cells,31–33 we next determined whether the inhibition of tumor metastasis by EHF knockdown was mediated by the TGF-β/SMAD signaling. The gene discussed is TGFB1; the disease is cancer.